Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

FDA provides positive review of InNexus Biotechnology development plan for lead preclinical candidate

InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).

2 Apr 2009

World's first nanofluidic device with complex 3-D surfaces

Researchers at the Commerce Department's National Institute of Standards and Technology (NIST) and Cornell University have capitalized on a process for manufacturing integrated circuits at the nanometer (billionth of a meter) level and used it to develop a method for engineering the first-ever nanoscale fluidic (nanofluidic) device with complex three-dimensional surfaces.

1 Apr 2009

University of Nottingham back pain study wins prestigious research prize

A study aimed at overcoming problems with treatments for a common cause of back pain has picked up one of the most prestigious prizes in spinal research.

31 Mar 2009

Protecting the public from food-borne illness and food associated hazards are main goal as addressed by food scientist

At the Institute of Medicine (IOM) and National Research Council (NRC) meeting held on March 24, Institute of Food Technologists (IFT) food scientist Dr. Frank Busta addressed food safety gaps in the Food Protection Plan by the U.S. Food and Drug Administration (FDA).

30 Mar 2009

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

30 Mar 2009

FDA approves IXIARO for Japanese encephalitis

The U.S. Food and Drug Administration has approved IXIARO, a vaccine to prevent Japanese encephalitis (JE) which is caused by a mosquito-transmitted virus found mainly in Asia. IXIARO will be the only vaccine for JE available in the United States.

30 Mar 2009

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Sagent Pharmaceuticals, Inc. has announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use.

26 Mar 2009

USAID switching to cheaper condoms produced overseas

USAID -- which has distributed an estimated 10 billion U.S.-manufactured condoms worldwide -- is switching to less-expensive condoms made overseas, the Kansas City Star reports.

24 Mar 2009

Researchers identify genetic machinery responsible for synthesizing thiostrepton

Researchers at the Georgia Institute of Technology have identified the genetic machinery responsible for synthesizing thiostrepton, a powerful antibiotic produced by certain bacteria.

23 Mar 2009

Warner Chilcott files new lawsuit for infringement of DORYX patent

Warner Chilcott Limited has announced hat one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic.

20 Mar 2009

New TB vaccine developed using a genetically modified adenovirus

McMaster University researchers are about to launch Canada's first tuberculosis (TB) vaccine clinical trial with a vaccine totally designed, manufactured and tested within McMaster.

20 Mar 2009

Examining the infinitesimal - new approach to microscopy

A new approach to microscopy is opening up the wonders of the molecular world, allowing researchers to examine organic molecules and delicate crystals as they grow, atom by atom. Dr Andrew Humhpris, co-founder of the original technology and now Chief Technology Officer of Infinitesima, explains how this University spin-out has turned into a leading-edge company.

17 Mar 2009

Nobilon's intranasal influenza vaccine begins phase I clinical development

Nobilon, the human vaccine business unit of Schering-Plough Corporation has announced that it has reached an important milestone with the initiation of its first-in-human clinical development program for SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use.

15 Mar 2009

ADMEcell enters into manufacturing and distribution agreement with Advancell

ADMEcell, announced that it has entered into an exclusive agreement with Advancell, Barcelona, Spain, to manufacture and distribute the CacoReady System for the North American market.

15 Mar 2009

Roche (SWX: ROG.VX; RO.S) and Genentech (NYSE:DNA) agree to combine

Roche and Genentech announced today that they signed a merger agreement under which Roche will acquire the outstanding publicly held interest in Genentech for US$95.00 per share in cash, or a total payment of approximately US$46.8 billion to equity holders of Genentech other than Roche.

12 Mar 2009

Skinvisible granted Japanese patent for Invisicare

Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'

11 Mar 2009

Extra workplace decibels increase risks of work-related accidents and road collisions

The majority of the 650,000 employees from Quebec's manufacturing sector - specifically those working in metallurgy and sawmilling - are exposed to noise levels that exceed governmental norms.

11 Mar 2009

Synthetic biology extends anti-malaria drug artemisinin's effectiveness

In addition to providing a simple and much less expensive means of making artemisinin, the most powerful anti-malaria drug in use today, synthetic biology can also help to extend the effectiveness of this drug.

8 Mar 2009

FDA shuts down a flour tortilla manufacturer for repeated violations

The U.S. Food and Drug Administration (FDA) has announced that Del Rey Tortilleria Inc., Chicago, Ill., its president, and two general managers have entered into a consent decree of permanent injunction that prevents Del Rey Tortilleria from manufacturing and distributing soft-shell flour tortillas until the company obtains FDA approval.

8 Mar 2009

Ranbaxy secures FDA approval for quinapril hydrochloride + hydrochlorothiazide tablets

Ranbaxy Pharmaceuticals has announced approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg.

5 Mar 2009